Navocaftor by Sionna Therapeutics for Cystic Fibrosis: Likelihood of Approval

Navocaftor is under clinical development by Sionna Therapeutics and currently in Phase II for Cystic Fibrosis.

Pelorus Securitizes $70 Million of Cannabis-Linked Real Estate Assets

Pelorus Capital Group Prices First-Ever Securitization Backed By Collateral in the Cannabis Sector Company to Retain One-Third of $70M Offering, Selling $45M of Bonds; Securitization

July 31, 2023

Mortality Reaches 20% for Hospitalized Patients With High-Risk Pulmonary Embolism

Mortality rates were high among patients with high-risk pulmonary embolism (PE), with the worst outcomes in those with hemodynamic collapse, according to a retrospective analysis

January 2, 2024

RFK Jr. Explains Why His Voice Sounds Hoarse

Welcome to Culture Clinic, MedPage Today‘s collaboration with Northwell Health to offer a healthcare professional’s take on the latest viral medical topics. Independent presidential candidate

May 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.